ZA945639B - Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitillis - Google Patents

Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitillis

Info

Publication number
ZA945639B
ZA945639B ZA945639A ZA945639A ZA945639B ZA 945639 B ZA945639 B ZA 945639B ZA 945639 A ZA945639 A ZA 945639A ZA 945639 A ZA945639 A ZA 945639A ZA 945639 B ZA945639 B ZA 945639B
Authority
ZA
South Africa
Prior art keywords
dehydrogenase complex
chain alpha
genes encoding
ketoacid dehydrogenase
novel
Prior art date
Application number
ZA945639A
Other languages
English (en)
Inventor
Claudio D Denoya
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA945639B publication Critical patent/ZA945639B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/04—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with a disulfide as acceptor (1.2.4)
    • C12Y102/04004—3-Methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) (1.2.4.4), i.e. branched-chain-alpha-ketoacid dehydrogenase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA945639A 1993-07-30 1994-07-29 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitillis ZA945639B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10051893A 1993-07-30 1993-07-30

Publications (1)

Publication Number Publication Date
ZA945639B true ZA945639B (en) 1996-01-29

Family

ID=22280171

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945639A ZA945639B (en) 1993-07-30 1994-07-29 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitillis

Country Status (22)

Country Link
US (1) US5728561A (es)
EP (1) EP0711349B1 (es)
JP (1) JP2807348B2 (es)
KR (1) KR100221385B1 (es)
CN (2) CN1104502C (es)
AT (1) ATE248916T1 (es)
AU (2) AU6657294A (es)
BR (1) BR9407211A (es)
CA (1) CA2167520C (es)
CZ (3) CZ26096A3 (es)
DE (1) DE69433112T2 (es)
DK (1) DK0711349T3 (es)
ES (1) ES2204914T3 (es)
FI (1) FI960401A0 (es)
HU (1) HU218964B (es)
IL (2) IL110430A (es)
NO (2) NO321077B1 (es)
NZ (2) NZ266014A (es)
PL (3) PL177922B1 (es)
PT (1) PT711349E (es)
WO (1) WO1995004150A1 (es)
ZA (1) ZA945639B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466102A (en) * 1993-12-16 1995-11-14 Kennametal Inc. System for coupling machine tools
AU8473198A (en) * 1997-06-30 1999-01-19 Curators Of The University Of Missouri, The Use of dna encoding plastid pyruvate dehydrogenase and branched chain oxoa cid dehydrogenase components to enhance polyhydroxyalkanoate biosynthesis in p lants
US6248579B1 (en) 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
US6197591B1 (en) 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
OA11998A (en) 1999-08-12 2006-04-18 Pfizer Prod Inc Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins.
DE60034953T2 (de) * 1999-08-19 2008-01-24 Omniscience Pharmaceuticals, Tempe Genklonierung
CN1321684A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人krab包含的锌指蛋白kraz2－12和编码这种多肽的多核苷酸
CN1321752A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人分支alpha－酮酸脱氢酶E1－beta亚单位9和编码这种多肽的多核苷酸
AT410217B (de) * 2000-06-15 2003-03-25 Cistem Biotechnologies Gmbh Vektor und ein verfahren zur expression und selektion randomisierter peptid-sequenzen
EP2141236A1 (en) 2008-07-03 2010-01-06 KRKA, D.D., Novo Mesto Process for production of lipstatin and microorganisms therefore
CN112410389B (zh) * 2019-08-23 2023-07-18 中国科学院微生物研究所 支链α-酮酸脱氢酶复合体在制备丙二酸单酰辅酶A中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284176B1 (en) * 1987-01-23 1993-08-25 Pfizer Inc. Process for production of avermectins and cultures therefor
IN167980B (es) * 1987-01-23 1991-01-19 Pfizer

Also Published As

Publication number Publication date
NO20052209L (no) 1996-01-29
ATE248916T1 (de) 2003-09-15
PL181916B1 (en) 2001-10-31
HUT71323A (en) 1995-11-28
AU9421898A (en) 1999-03-04
WO1995004150A1 (en) 1995-02-09
AU712442B2 (en) 1999-11-04
IL110430A0 (en) 1994-10-21
FI960401A (fi) 1996-01-29
CN1104502C (zh) 2003-04-02
NO20052209D0 (no) 2005-05-04
CA2167520A1 (en) 1995-02-09
AU6657294A (en) 1995-02-28
CA2167520C (en) 1999-07-27
BR9407211A (pt) 1996-09-17
EP0711349A1 (en) 1996-05-15
HU9402192D0 (en) 1994-10-28
DK0711349T3 (da) 2003-11-24
PL181778B1 (pl) 2001-09-28
US5728561A (en) 1998-03-17
FI960401A0 (fi) 1996-01-29
ES2204914T3 (es) 2004-05-01
CN1128046A (zh) 1996-07-31
CZ289136B6 (cs) 2001-11-14
HU218964B (hu) 2001-01-29
PL312733A1 (en) 1996-05-13
CN1208078A (zh) 1999-02-17
PL177922B1 (pl) 2000-01-31
EP0711349B1 (en) 2003-09-03
NO321077B1 (no) 2006-03-13
NO960372D0 (no) 1996-01-29
CZ289866B6 (cs) 2002-04-17
DE69433112T2 (de) 2004-04-01
JPH08507931A (ja) 1996-08-27
PT711349E (pt) 2003-12-31
JP2807348B2 (ja) 1998-10-08
IL154136A0 (en) 2003-07-31
DE69433112D1 (de) 2003-10-09
KR100221385B1 (ko) 1999-10-01
CZ26096A3 (en) 1996-05-15
IL110430A (en) 2005-08-31
NZ266014A (en) 1997-11-24
CZ20002929A3 (cs) 2001-11-14
NZ328926A (en) 1998-02-26
NO960372L (no) 1996-01-29

Similar Documents

Publication Publication Date Title
NO20052209D0 (no) Fremgansmate for fremstilling av nytt og naturlig avermektin
JPS6416589A (en) Development of human proapolipoprotein a-1
MX9602993A (es) Hormona del crecimiento humano.
EP0833912A4 (en) NEW TRANSFORMING GROWTH FACTOR TYPE CYTOKINE TGF-BETA
NO853012L (no) Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.
WO2001051639A3 (en) Everninomicin biosynthetic genes
NO20070802L (no) Gener som koder for forgrent-kjede alfa-ketosyre-dehydrogenase-kompleks fra Streptomyces avermitilis.
AU1682092A (en) Production of plants resistant to attacks of sclerotinia sclerotiorum by introducing a gene coding for an oxalate oxidase
GR3021071T3 (en) Method for producing clavulanic acid
WO1994000463A3 (en) Production of hyaluronic acid by transeformed microorganisms
JPS6427477A (en) Dna and use thereof
IL94053A0 (en) Methods and nucleic acid sequences for the expression of the cellulose synthase operon
IL111608A0 (en) Tyrosinase-activator protein fusion enzyme
EP0196223A3 (en) Dedicated ribosomes and their use in producing protein in cell culture
AU7300998A (en) Receptor tyrosine kinase genes
MXPA05002852A (es) Polipeptidos implicados en la biosintesis de espiramicinas, secuencias de nucleotidos que codifican estos polipeptidos y sus aplicaciones.
ES2013184A6 (es) Un procemiento para producir un activador de plasminogeno de tipo tejido (t-pa) mejorado.